Martin Capital Advisors LLP Lowers Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Martin Capital Advisors LLP lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,374 shares of the financial services provider’s stock after selling 96 shares during the period. iShares Biotechnology ETF accounts for 1.5% of Martin Capital Advisors LLP’s investment portfolio, making the stock its 21st largest holding. Martin Capital Advisors LLP’s holdings in iShares Biotechnology ETF were worth $1,817,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Glass Jacobson Investment Advisors llc raised its stake in shares of iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 122 shares during the last quarter. PCA Investment Advisory Services Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $28,000. Values First Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $43,000. Horizon Bancorp Inc. IN purchased a new stake in iShares Biotechnology ETF in the 3rd quarter valued at approximately $44,000. Finally, Tennessee Valley Asset Management Partners acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $44,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock traded up $0.08 during trading hours on Friday, reaching $124.72. The stock had a trading volume of 1,996,592 shares, compared to its average volume of 1,809,704. The firm has a 50 day simple moving average of $135.29 and a two-hundred day simple moving average of $129.51. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.40%. The ex-dividend date of this dividend was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.